Stock Watch: The Meaning Of Biosimilar Success
Big Pharma, Generic Or Biotech Firms: Which Will Be The Long-Term Winners?
With two recent divestments of biosimilar franchises and lackluster performances from smaller biosimilar biotechs, the sector needs some standard-bearing successes.
